Katherine Hoggatt

Katherine Hoggatt, PhD, MPH, is an Associate Professor affiliated with the University of California, San Francisco (UCSF), with a strong focus on public health, epidemiology, and healthcare disparities. Her research emphasizes substance use disorders, veteran health outcomes, and healthcare quality improvement. She has contributed extensively to understanding cannabis use among older adults, opioid use disorder treatment strategies, and disparities in access to care for vulnerable populations.

Her work integrates machine learning and predictive analytics to improve diagnostic measures and treatment retention for substance use disorders. Notable projects include analyzing the impact of cannabis legalization on substance use patterns and evaluating vaccination strategies for severe COVID-19 outcomes in high-risk cohorts. Dr. Hoggatt’s research often bridges clinical and population-level data to inform policy and practice, particularly within Veterans Health Administration systems.

Key areas of investigation include smoking cessation among veterans prescribed opioids, the management of long-term opioid therapy risks, and disparities in genetic testing adoption for cancer patients. Her publications frequently address behavioral health challenges, such as improving engagement in substance use treatment and mitigating suicide risks linked to smoking behaviors.

Dr. Hoggatt collaborates with interdisciplinary teams to address complex health issues, leveraging large-scale datasets and observational studies. Her work highlights the intersection of social determinants of health, clinical practice, and public health policy, aiming to optimize healthcare delivery for marginalized groups, including veterans and minority populations.